Updates in the Management of Macular Degeneration
Age-related macular degeneration (ARMD) affects roughly 11 million people in the US and is the leading cause of visual impairment for older individuals. Its severe and rapid impact on vision requires vigilant prevention and screening practices, as well as a thorough understanding of diagnostic procedures and the optimal use of current and emerging therapies. This activity will provide an overview of the multiple subtypes of ARMD, including dry, intermediate, and wet ARMD, and geographic atrophy. It will explore existing and emerging therapies for ARMD subtypes, as well as their efficacy and safety profiles. In addition, testing strategies that can help determine the direction of ARMD management plans, as well as applications and programs for low-vision care, will be identified.
This activity is provided by Optum Health Education and UnitedHealthcare Vision.
No commercial support was received for this activity.
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
This activity is designed to meet the educational needs of optometrists who have an interest in managing patients with macular degeneration.
At the end of this activity, participants should be able to:
- Discuss the different types of ARMD, related risk factors and prevention strategies.
- Examine data on current and emerging therapies for ARMD subtypes including safety and efficacy profiles.
- Explore management plans for ARMD, including rehabilitation programs and low-vision care–related tool utilization, and the testing strategies that can guide these plans.
Scott Edmonds, OD, FAAO
Chief Eyecare Officer
Emeritus Co-Director of the Low Vision, Contact Lens and Brain Injury Rehabilitation Service
Wills Eye Hospital
Sunir J. Garg, MD, FACS, FASRS
Professor of Ophthalmology
Co-Director Retina Research Unit
The Retina Service of Wills Eye Hospital
Thomas Jefferson University
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Optum Health Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
Dr. Garg has disclosed that he serves on an Advisory Board for Coherus; he is a consultant for American Academy of Ophthalmology, Apellis, Bausch & Lomb, Boehringer Ingelheim, Coherus, Kanaph, and Merck Manual; he receives grant/research support from American Academy of Ophthalmology, Apellis, Boehringer Ingelheim, Genentech, Kodiak Biosciences, NGM Bio and Regeneron; and he receives other financial or material support from Bausch & Lomb, Canadian Ophthalmological Society, Cole Eye Summit, and Retina Fellows Forum. The remaining activity faculty and planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
In support of improving patient care, this activity has been planned and implemented by Optum Health Education and UnitedHealthcare Vision. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit designation statements
Optum Health Education designates this enduring activity for a maximum of 1.0 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization from which they wish to obtain credit.
- 1.00 Attendance - General Attendance
- 1.00 COPE - Optometrists
You must be logged into your account to participate in this activity. Get started by clicking “Register/Continue” and following the instructions. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”